Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Enzalutamide + Exemestane in Advanced Breast Cancer
NCT02007512Phase 2Completed
- Sponsor
- Pfizer
- Start
- Dec 2013
- Primary completion
- Sep 2016
- Modality
- Small Molecules
- Countries
- 7
01
Overview
A Phase 2 trial of enzalutamide in breast cancer, sponsored by Pfizer. Started Dec 2013; status: completed.
02
Drugs
enzalutamide
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT02007512.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02007512.